There is more to choosing drugs for the intensive care unit than cost. How effective a particular agent is may be even more important than how much it costs.
Medication, Health Care Affordability Improved During COVID-19 Pandemic
Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.
Reach Your Business Goals in 2021
In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.
GLP-1s, SGLT2 Inhibitors Reduce Progression of CKD
In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.
ThoughtSpot Series: Closing the Healthcare Gap
Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.
FDA Approves Updated Label for Altuviiio for Effective Bleed Protection in Children Younger than 12 Years
Altuviiio was first granted approval by the FDA in February 2023.
Q&A: Inside the Vanderbilt Specialty Pharmacy-AstraZeneca Collaboration
A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.